These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Further evidence of association between amphetamine response and SLC6A2 gene variants. Dlugos AM; Hamidovic A; Palmer AA; de Wit H Psychopharmacology (Berl); 2009 Oct; 206(3):501-11. PubMed ID: 19727679 [TBL] [Abstract][Full Text] [Related]
3. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. Hamidovic A; Childs E; Conrad M; King A; de Wit H Drug Alcohol Depend; 2010 Jun; 109(1-3):175-80. PubMed ID: 20176450 [TBL] [Abstract][Full Text] [Related]
4. No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA. Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME Eur J Clin Pharmacol; 2018 Mar; 74(3):275-283. PubMed ID: 29198060 [TBL] [Abstract][Full Text] [Related]
5. Subjective responses predict d-amphetamine choice in healthy volunteers. Murray CH; Li J; Weafer J; de Wit H Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Hamidovic A; Dlugos A; Skol A; Palmer AA; de Wit H Exp Clin Psychopharmacol; 2009 Dec; 17(6):374-83. PubMed ID: 19968402 [TBL] [Abstract][Full Text] [Related]
7. Serotonin transporter genotype and acute subjective response to amphetamine. Lott DC; Kim SJ; Cook EH; de Wit H Am J Addict; 2006; 15(5):327-35. PubMed ID: 16966188 [TBL] [Abstract][Full Text] [Related]
8. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Kirkpatrick MG; Goldenson NI; Kapadia N; Kahler CW; de Wit H; Swift RM; McGeary JE; Sussman S; Leventhal AM Psychopharmacology (Berl); 2016 Jan; 233(1):89-97. PubMed ID: 26429791 [TBL] [Abstract][Full Text] [Related]
10. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder. Shang CY; Chiang HL; Gau SS Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436 [TBL] [Abstract][Full Text] [Related]
11. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers. Pester MS; Kirkpatrick MG; Geary BA; Leventhal AM J Psychopharmacol; 2018 Mar; 32(3):302-308. PubMed ID: 29338486 [TBL] [Abstract][Full Text] [Related]
12. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients. Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517 [TBL] [Abstract][Full Text] [Related]
13. More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine. Dlugos AM; Hamidovic A; Hodgkinson CA; Goldman D; Palmer AA; de Wit H Neuropsychopharmacology; 2010 Feb; 35(3):613-22. PubMed ID: 19890266 [TBL] [Abstract][Full Text] [Related]
14. Effects of amphetamine on reactivity to emotional stimuli. Wardle MC; de Wit H Psychopharmacology (Berl); 2012 Mar; 220(1):143-53. PubMed ID: 21947316 [TBL] [Abstract][Full Text] [Related]
15. Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations. Belfer I; Phillips G; Taubman J; Hipp H; Lipsky RH; Enoch MA; Max MB; Goldman D J Hum Genet; 2004; 49(5):232-45. PubMed ID: 15362567 [TBL] [Abstract][Full Text] [Related]
16. Inattention, impulsive action, and subjective response to D-amphetamine. Weafer J; de Wit H Drug Alcohol Depend; 2013 Nov; 133(1):127-33. PubMed ID: 23790566 [TBL] [Abstract][Full Text] [Related]
17. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Dong C; Wong ML; Licinio J Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206 [TBL] [Abstract][Full Text] [Related]
18. Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis. Houston JP; Lau K; Aris V; Liu W; Fijal BA; Heinloth AN; Perlis RH J Clin Psychiatry; 2012 Jun; 73(6):878-85. PubMed ID: 22480387 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. Hamidovic A; Dlugos A; Palmer AA; de Wit H Behav Genet; 2010 Mar; 40(2):255-61. PubMed ID: 20091113 [TBL] [Abstract][Full Text] [Related]
20. Personality and the acute subjective effects of d-amphetamine in humans. Kirkpatrick MG; Johanson CE; de Wit H J Psychopharmacol; 2013 Mar; 27(3):256-64. PubMed ID: 23343596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]